Merck & Co., Inc. is a company in the U.S. stock market and it is a holding in 315 U.S.-traded ETFs. MRK has around 242.0M shares in the U.S. ETF market. The largest ETF holder of MRK is the SPDR S&P 500 ETF Trust (SPY), with approximately 26.81M shares. Investors may also find of interest that the ETF with the largest allocation to MRK stock is Pacer BioThreat Strategy ETF (VIRS), with a portfolio weight of 6.94%. On average, U.S. ETFs allocate 1.33% of MRK to their portfolios.
Additionally, MRK is a favorite stock for Active and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MRK as a holding is the AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL), with a return of 16.53%.